Clinical Trials Logo

Clinical Trial Summary

Renal artery stenosis is one the leading cause of secondary hypertension. Previous randomized controlled trials in humans have failed to demonstrate an improvement of renal function after stenosis dilation, probably because of a selection bias with more severe patients being excluded from randomization. Renal ischemia-reperfusion injuries have also not been taken into account. Indeed, reperfusion leads to a rapid renal blood flow recovery associated with renal ischemia-reperfusion injuries. Mitochondrial permeability transition pore (mPTP) is a key player in the occurrence of ischemia reperfusion injuries because its opening leads to mitochondria leakage and cell death. However, preconditioning whether pharmacological or ischemic can prevent mPTP opening and protect cells. Ciclosporin A can prolong mPTP closing during reperfusion and reduce renal and cardiac tissular lesions. Another mPTP blocker (Bendavia) has been associated with an improvement of renal blood flow (RBF) and glomerular filtration rate (GFR) after renal artery stenosis dilation at 6 weeks in pigs. Based on a recent study, dilation overall benefit could be secondary to an improvement of the contralateral kidney GFR and tissue oxygen content, requiring a single kidney evaluation of those renal functional parameters. The investigators previously demonstrated that dose and timing of ciclosporin A preconditioning is key to protect kidneys from ischemia-reperfusion injuries. Previous controlled trials that failed to demonstrate a benefit of ciclosporin A conditioning have used post conditioning on necrotic cells. Considering kidney ischemia-reperfusion injuries, preconditioning have led to more encouraging results compared to ciclosporin A post conditioning in animals. Therefore the investigators aim to conduct the first clinical study of ciclosporin A preconditioning for prevention of kidney ischemia-reperfusion injuries after renal artery stenosis dilation. Using renal functional imaging and the new PET-MRI (Positron Emission Tomography-Magnetic Resonance Imaging) combined device, the investigators will evaluate kidney perfusion, oxidative metabolism, glomerular filtration rate and oxygen content before and 3 months after renal artery stenosis dilation with or without a ciclosporin A preconditioning.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03382301
Study type Interventional
Source Hospices Civils de Lyon
Contact
Status Completed
Phase Phase 2
Start date August 28, 2018
Completion date June 18, 2020

See also
  Status Clinical Trial Phase
Completed NCT02528149 - Renal Arteries Dysplastic Aneurysms: Anatomopathological and Genetic Study N/A
Completed NCT02476526 - Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease Phase 4
Completed NCT00209391 - A Safety & Efficacy Clinical Study to Evaluate the Narrowing of the Renal Arteries While Using Gadodiamide Phase 3
Completed NCT01673373 - Renal Stent Placement for the Treatment of Renal Artery Stenosis in Patients With Resistant Hypertension N/A
Completed NCT02266394 - Hypoxia and Inflammatory Injury in Human Renovascular Hypertension Phase 1
Recruiting NCT02388139 - Cardiovascular, Renal and Metabolic Profile in Patients With Acute Myocardial Infarction (REN-ACS) N/A
Active, not recruiting NCT01023373 - Revascularization of Renal Artery Stenosis Versus Medical Therapy for the Treatment of Ischemic Nephropathy Phase 4
Recruiting NCT05603221 - Renal Perfusion Assessment in the Endovascular Treatment of Renal Artery Stenosis
Recruiting NCT03252639 - A Study of Using Parenchymal Blood Volume(PBV) for Endovascular Treatment of Renal Arterial Stenosis N/A
Completed NCT00235157 - A Comparison of Coated and Uncoated Stents in Renal Artery Treatment. Phase 2
Completed NCT00001313 - Evaluation of Patients With Known or Suspected Heart Disease N/A
Not yet recruiting NCT05612438 - RADIX 2 RENAL STENT Post-Market Retrospective Study
Withdrawn NCT03914157 - Ultrasound Wave Therapy for Post-stenotic Microvascular Remodeling N/A
Completed NCT01128933 - Renal Fractional Flow Reserve in Renal Artery Stenting N/A
Recruiting NCT03594786 - Impact of Supra-renal Fixation of EVAR on Hemodynamics of Renal Arteries N/A
Completed NCT00885768 - Prevalence of Renal Artery Stenosis in Patients Referred for Cardiac Catheterization Phase 3
Completed NCT04423458 - Evaluation of Advanced US Tools in Assessing Allograft Complications
Recruiting NCT02655341 - Hydration Status Assessment Through Body Composition Monitoring in Patients With Acute Myocardial Infarction N/A
Completed NCT01576835 - Renal Artery Contrast-Free Trial Phase 4
Completed NCT01057316 - Formula PTX Renal Stent Clinical Study N/A